ABCC8 polymorphisms are associated with triglyceride concentration in type 2 diabetics on sulfonylurea therapy.

scientific article

ABCC8 polymorphisms are associated with triglyceride concentration in type 2 diabetics on sulfonylurea therapy. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1089/GTMB.2011.0337
P8608Fatcat IDrelease_me4hs2g5wrfl3cjeret22kye24
P698PubMed publication ID22533711

P50authorNora Nikolac GabajQ61163252
Ana-Maria SimundicQ37829129
Andrea SaracevicQ54260595
Darko KatalinicQ60391147
P2093author name stringAndrea Saracevic
Nora Nikolac
Darko Katalinic
P433issue8
P921main subjecttriglycerideQ186319
P304page(s)924-930
P577publication date2012-04-25
P1433published inGenetic Testing and Molecular BiomarkersQ15753742
P1476titleABCC8 polymorphisms are associated with triglyceride concentration in type 2 diabetics on sulfonylurea therapy
P478volume16

Reverse relations

cites work (P2860)
Q92226434A Variation in the ABCC8 Gene Is Associated with Type 2 Diabetes Mellitus and Repaglinide Efficacy in Chinese Type 2 Diabetes Mellitus Patients
Q51245201CYP3A4 and GCK genetic polymorphisms are the risk factors of tacrolimus-induced new-onset diabetes after transplantation in renal transplant recipients.
Q33771570KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment.
Q37508445Pharmacogenetics and personalized treatment of type 2 diabetes
Q99605020Pharmacogenetics of Type 2 Diabetes-Progress and Prospects
Q90267161Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine
Q92508730Utility of Precision Medicine in the Management of Diabetes: Expert Opinion from an International Panel

Search more.